Intracameral amphotericin B injection in the management of deep keratomycosis

Cornea

Volumn 21, Issue 7, 2002, Pages 653-656

  Kuriakose, Thomas ^a   Kothari, Mihir ^a   Paul, Padma ^a   Jacob, Pushpa ^a   Thomas, Ravi ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Amphotericin B treatment; Corneal ulcer; Fungal keratitis; Intracameral injection; Keratomycosis

Indexed keywords

AMPHOTERICIN B; ANTIVIRUS AGENT; BETAMETHASONE; CHLORAMPHENICOL DERIVATIVE; DEXAMETHASONE; FLUCONAZOLE; KETOCONAZOLE; NATAMYCIN; TOBRAMYCIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA ULCER; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HYPOPYON; KERATOMYCOSIS; MALE; PAIN; PRIORITY JOURNAL; SYMPTOM; TREATMENT FAILURE;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CORNEAL ULCER; EYE; EYE EVISCERATION; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; INJECTIONS; MALE; MIDDLE AGED; RETREATMENT; TREATMENT OUTCOME;

EID: 0036784873     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200210000-00004     Document Type: Article

References (19)

1. Johns KJ, O'Day DM. Pharmacologic management of keratomycosis. Surv Ophthalmol 1988;33:178-88.
2. O'Day DM. Selection of appropriate antifungal therapy. Cornea 1987; 6:238-45.
3. Panda A, Vajpayee RB, Kumar TS. Critical evaluation of therapeutic keratoplasty in cases of keratomycosis. Ann Ophthalmol 1991;23: 373-6.
4. Forster RK, Rebell G. Therapeutic surgery in failures of medical treatment for fungal keratitis. Br J Ophthalmol 1975;59:366-71.
5. Naumann G, Green WR, Zimmerman LF. Mycotic keratitis. A histopathologic study of 73 cases. Am J Ophthalmol 1967;64:668-82.
6. Pleyer U, Grammer J, Pleyer JH, et al. Amphotericin-B-bioavailability in the cornea. Studies with local administration of liposome-incorporated amphotericin B. Ophthalmologe 1995;92: 469-75.
7. Manger TF. Antimicrobials, In: Mauger TF, Craig EL, eds. Havener's ocular pharmacology. St. Louis: Mosby, 1994:313-24.
8. Souri EN, Green WR. Intravitreal amphotericin-B toxicity. Am J Ophthalmol 1974;78:77-81.
9. Thomas PA, Kuriakose T, Kirupashankar MP, et al. Use of lactophenol cotton blue mounts of corneal scrapings as an aid to the diagnosis of mycotic keratitis. Diagn Microbiol Infect Dis 1991;14:219-24.
10. Cutler JE, Binder PS, Paul TO, et al. Metastatic coccidioidal endophthalmitis. Arch Ophthalmol 1978;96:689-91.
11. Jones BR. Principles in the management of ocular mycosis. Am J Ophthalmol 1975;79:719-51.
12. Gilbert CM, Novak MA. Successful treatment of postoperative Candida endophthalmitis in an eye with an intraocular lens implant. Am J Ophthalmol 1984;97:593-5.
13. Ritterband DC, Shah M, Seedor JA. Colletotrichum graminicola: a new corneal pathogen. Cornea 1997;16:362-4.
14. Kaushik S, Ram J, Brar GS, et al. Intracameral amphotericin B, initial experience in severe keratomycosis. Cornea 2001;20:715-9.
15. Foster JBT, Almeda E, Littman ML, et al. Some intraocular and conjunctival effects of amphotericin-B in man and in rabbits. Arch Ophthalmol 1958;60:555-64.
16. Wang HZ, Chang CH, Lin CP, et al. Using MTT viability assay to test the cytotoxicity of antibiotics and steroid to cultured porcine corneal endothelial cells. J Ocul Pharmacol Ther 1996;12:35-43.
17. Chang CH, Lin CP, Wang HZ. Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture. Cornea 1995;14:71-6.
18. Sandra FS, Russel LJ. Immunopotentiating effects of amphotericin B: 1. Enhanced contact sensitivity in mice. J Immunol 1979;123:2878-82.
19. Sandra FS, Russel LJ. Immunopotentiating effects of amphotericin B: 2. Enhanced in vitro proliferative responses of murine lymphocytes. J Immunol 1979;123:2883-8.